Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14
Financial Results Archives - The Pharma Times | Pharma & Health Care News Portal

Financial Results

Lincoln Pharmaceuticals Ltd reports Standalone Net Profit of Rs. 28.04 crore in Q3 FY24, 29.75% rise Y-o-Y

New Delhi, February 09, 2024: Company achieved Profit Before Tax of Rs. 100.02 crores for 9M FY24 ended December 2023,…

3 months ago

Lincoln Pharmaceuticals Ltd reports 22.8% rise in the Standalone Net Profit at Rs. 21.6 crore in Q3 FY23

Highlights:- Total Income in Q3 FY23 at Rs. 140.12 crore, up 14.4% from Rs. 122.5 crore in Q3 FY22 During the year,…

1 year ago

Hester Biosciences Limited Q2 & H1 FY23 Results

Standalone revenue up by 27% and 6% for Q2 and H1 FY23  Consolidated revenue up by 17% and 1% for…

1 year ago

Hester Biosciences Ltd reports Net Profit of Rs. 3.56 crore and Revenues from Operations of Rs. 50.7 crore in Q1FY23

Ahmedabad, August 11, 2022: One of India's leading poultry and animal vaccine manufacturing company, Hester Biosciences Limited has reported consolidated net profit of…

2 years ago

Balaxi Pharmaceuticals reports continued solid growth in Q1 FY23

Revenue grows 42% in Q1FY23 Pharma Revenue in Latin America up 39%                 …

2 years ago

Hester Biosciences Limited Q4 and FY22 Results

- FY22 Standalone revenues up 5%, Consolidated revenues up 10% - FY22 Standalone PAT down 1%, Consolidated PAT up 14%…

2 years ago

Lincoln Pharma reports Best-Ever Results in a Financial Year; Reports Highest Revenue, EBIDTA, Net Profit in FY22

Company recommends 15% dividend, Rs. 1.50 per share for FY 22  FY22 Results Highlights:- (Standalone) ·         Net Profit Reports Y-o-Y…

2 years ago

Alembic Pharmaceuticals Reports Net Profit of Rs 176 Crores in Q3FY22

India Branded business up 17% Financial Highlights Net Sales for the quarter at Rs 1272 crores. Net Profit for the…

2 years ago

Lincoln Pharmaceuticals Ltd reports 30.50% rise in the Standalone Net Profit at Rs. 17.60 crore in Q3 FY22

Highlights:- •           Net revenues in Q3 FY22 at Rs. 122.52 crore, up 6.18% from Rs. 115.39 crore in Q3 FY21;…

2 years ago

Venus Remedies Net Profit Registers 51.88% Increase

The company’s net profit grew to Rs 40.49 crore in the nine-month period ending December 31, 2021 as compared to…

2 years ago